Glaukos (GKOS) Interest & Investment Income (2014 - 2026)
Glaukos' (GKOS) quarterly Interest & Investment Income came in at $2.3 million in Q2 2026, down 11.46% year-over-year from $2.6 million in Q2 2025, and down 6.25% quarter-over-quarter from $2.4 million in Q1 2026.
Analysis
Glaukos (GKOS) Interest & Investment Income (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has reported Interest & Investment Income for 13 consecutive years, with $2.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Interest & Investment Income fell 11.46% year-over-year to $2.3 million in Q2 2026; TTM through Jun 2026 was $9.8 million, a 9.87% decrease from a year earlier, with the FY2025 full-year figure at $10.7 million, down 3.52% from the prior year.
- Interest & Investment Income was $2.3 million for Q2 2026 at Glaukos, down from $2.4 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $12.2 million in Q4 2022 and troughed at -$5.9 million in Q2 2022.
- A 5-year average of $2.1 million and a median of $2.5 million in 2025 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income slumped 1810.82% in 2022 and jumped 271.67% in 2023, its largest moves.
- Over 5 years, Interest & Investment Income stood at $12.2 million in 2022, then tumbled by 76.07% to $2.9 million in 2023, then dropped by 14.35% to $2.5 million in 2024, then gained by 0.72% to $2.5 million in 2025, then decreased by 9.28% to $2.3 million in 2026.
- The last three Interest & Investment Income figures came in at $2.3 million (Q2 2026), $2.4 million (Q1 2026), and $2.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.57 Bn | 178.97 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.29 Bn | 109.47 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.60 Bn | 101.12 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.50 Bn | 65.97 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn | 30.00 Mn |
| 7 | Alcon | 33.97 Bn | 32.51 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.23 Bn | 30.29 Bn | 830.00 Mn | - |
| 9 | Steris | 21.16 Bn | 20.68 Bn | 684.20 Mn | - |
| 10 | Glaukos | 10.68 Bn | 10.57 Bn | 151.59 Mn | 2.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.28 Mn |
| Mar 31, 2026 | 2.43 Mn |
| Dec 31, 2025 | 2.51 Mn |
| Sep 30, 2025 | 2.55 Mn |
| Jun 30, 2025 | 2.57 Mn |
| Mar 31, 2025 | 3.08 Mn |
| Dec 31, 2024 | 2.49 Mn |
| Sep 30, 2024 | 2.70 Mn |
| Jun 30, 2024 | 2.83 Mn |
| Mar 31, 2024 | 3.08 Mn |
| Dec 31, 2023 | 2.91 Mn |
| Sep 30, 2023 | 2.71 Mn |
| Jun 30, 2023 | 1.89 Mn |
| Mar 31, 2023 | 1.65 Mn |
| Dec 31, 2022 | 12.17 Mn |
| Sep 30, 2022 | -2.98 Mn |
| Jun 30, 2022 | -5.85 Mn |
| Mar 31, 2022 | -960,000.00 |
| Dec 31, 2021 | 4.39 Mn |
| Sep 30, 2021 | -1.47 Mn |